Seribantumab Completed Phase 1 Trials for Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer / Primary Peritoneal Cancer or Endometrial Cancer / Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer Treatment